Evaluation of the Anti-Cancer Effects of KMU-11342 in In Vitro and Ex Vivo Models of Colorectal Cancer.

Pharmaceuticals (Basel) · 2026 · PMC13415177 · PMID 42515669

Europe PMC DOI

hedged sentence

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

highly significantp < 0.0001actually significant

Compared with the control group, the 1 μM-treated group showed a significant reduction in viability ( p < 0.05), whereas the 2 μM-treated group exhibited a highly significant decrease ( p < 0.0001), as well as a significant reduction compared with the 1 μM-treated group ( p < 0.05).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.